CARE Center

A5383

A group of smiling people standing in front of a rainbow flag with the caption: "Do you want to participate in a study related to HIV & Aging? Explore a treatment that looks at whether an oral drug decreases inflammation."
A photo explaining the eligibility criteria for the study and an image of a red ribbon. The text reads: "This study investigates whether the oral drug letermovir decreases inflammation in people who have both HIV and CMV (cytomegalovirus)". Eligibility Criteria. Age 40 or older, HIV with undetectable viral load on HIV treatment for at least 48 weeks, Positive for CMV (the study will perform the test).

For more information, please contact the UCLA study team: (310) 843-2015 or [email protected]*

*There are limits to the confidentiality of email communications. Do not include any sensitive health information if you choose to contact the study team via email.